Farcast Biosciences

Farcast is human tumor microdynamics platform that predicts clinical response based on data from live human tumors. Our mission is to tell the truth about every patient tumor, every time and help improve outcomes for cancer patients.

Techstars

Accel

RA Capital Management

Sands Capital Ventures

Peak XV Partners

Alumni Ventures

Northpond Ventures

Satish Sankaran, Nandini Pal Basak, Kowshik Jaganathan, Biswajit Das, PhD, Jaromy Kuhl, David Bellar PhD FACSM FNSCA RFSA
#precisionmedicine #precisiononcology

Thank you for the overwhelming response to our posters presented at  the AACR meeting in Orlando earlier this month. Here is a link to the abstracts of our posters:
Poster 6632: Comparing response of Pembrolizumab and Nivolumab in the same patient by treating their tumors in an ex-vivo setting:
https://lnkd.in/gk-VHNBb
Poster 4568: Rescuing TKI failed RCC patients with Nivolumab
https://lnkd.in/gKATdWns
To download our AACR 2023 posters, visit us at 
https://lnkd.in/g4Kb8uw

Using Farcast's TruTumor technology, tumors from 6 HNSCC patients were simultaneously treated with Nivolumab and Pembrolizumab. The Tumor Microdynamic response was measured and compared using multi-omic assays.
To find out more about TruTumor and its versatile applications:
visit www.farcastbio.com or contact us at biopharma@farcastbio.com  
#immunooncology #precisiononcology #translationalresearch #trutumor #

The key to improving response rates and delivering durable benefits to patients is in understanding the dynamics and complexity of human tumor microenvironments. Johanna's excellent review is not only insightful, but also thought provoking!
Farcast hTMD (human Tumor Micro Dynamics) platform is based on understanding the mechanism and complexity of living human tumor fragments. 
We have curated a list of biomarkers associated with response and resistance to immune-checkpoint treatment. To download a free summary https://lnkd.in/gUvXVDUj

Tumors constantly shape their micro-environment by dynamic  signaling and communication with immune cells and constantly alter the immune and extracellular milieu. This allows tumor cells to create a tumor-supportive environment and induce neo-angiogenesis,  as well as activate a variety of mechanisms to hijack the micro-environment. 
Fighting cancer requires a deep understanding of tumor microdynamics and an intelligent decoding of myriad signals in every tumor, so that we can deliver durable benefits by directing appropriate therapies personalized for every tumor.
#tumormicroenvironment, #translationalresearch #immunooncology #tumormicrodynamics #cancerresearch #personalizedmedicine #precisiononcology

Farcast does not have any exposure to SVB and remains unaffected by the recent developments in the bank

It is hard to anticipate the activation of antitumor immune response during immunotherapy. The success of any immunotherapy is multifactorial and results from complex interplay between tumor, immune and stromal microenvironments.

For instance, PD-1/PD-L1 blockade is associated with multiple functional attributes of immunity. While numerous biomarkers exist for multiple tumor types, an accurate identification of responder phenotype is still evasive.

To find out more
https://lnkd.in/gUvXVDUj

Understanding tumor microdynamics is key to predicting response to immunotherapy.  When faced with failures like HPD,  use of combination therapies could come to rescue if one could ascertain the spatial and temporal intra-tumoral variability.

Mitra Biotech develops a diagnostic platform for personalized cancer treatment selection and drug development.

Mitra Biotech

Kiyatec is a competitor of Farcast Biosciences specializing in cancer treatment decision solutions.

Kiyatec

Turing Biosystems is a competitor of Farcast Biosciences in the field of cancer treatment decision solutions.

Turing Biosystems

Pear Bio is a competitor of Farcast Biosciences focusing on individualized treatment response predictions for patient-specific cancer treatment selection and drug discovery.

Pear Bio

NuProbe is a competitor of Farcast Biosciences in the field of cancer treatment decision solutions.

NuProbe

Lunaphore is a competitor of Farcast Biosciences specializing in cancer treatment decision solutions.

Lunaphore

Ultivue is a competitor of Mitra Biotech in the field of personalized cancer treatment selection and drug development.

Ultivue

Ohana Biosciences is a competitor of Mitra Biotech in the field of personalized cancer treatment selection and drug development.

Ohana Biosciences

Matterworks is a competitor of Mitra Biotech in the field of personalized cancer treatment selection and drug development.

Matterworks

Farcast Biosciences is a biotechnology company that specializes in developing computational tools to enhance the understanding of complex biological systems. Their platform integrates diverse data types to model diseases and identify potential therapeutic targets, with a focus on oncology and immunology.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 16, 2024 9:39 AM	f30e0f7e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 16, 2024 9:39 AM	f4740105
translate crunchbase fundingrounds	general
peers	general
news basic	general
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:FARCASTBIO

Farcast Biosciences